GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XBiotech Inc (STU:4XB) » Definitions » Cyclically Adjusted FCF per Share

XBiotech (STU:4XB) Cyclically Adjusted FCF per Share : €-0.75 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is XBiotech Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

XBiotech's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-0.225. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.75 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-16), XBiotech's current stock price is €5.80. XBiotech's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €-0.75. XBiotech's Cyclically Adjusted Price-to-FCF of today is .


XBiotech Cyclically Adjusted FCF per Share Historical Data

The historical data trend for XBiotech's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XBiotech Cyclically Adjusted FCF per Share Chart

XBiotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -0.72

XBiotech Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.74 -0.74 -0.74 -0.72 -0.75

Competitive Comparison of XBiotech's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, XBiotech's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


XBiotech's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, XBiotech's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where XBiotech's Cyclically Adjusted Price-to-FCF falls into.



XBiotech Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, XBiotech's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.225/131.7762*131.7762
=-0.225

Current CPI (Mar. 2024) = 131.7762.

XBiotech Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.068 100.560 -0.089
201409 -0.092 100.428 -0.121
201412 -0.102 99.070 -0.136
201503 -0.207 99.621 -0.274
201506 -0.299 100.684 -0.391
201509 -0.324 100.392 -0.425
201512 -0.412 99.792 -0.544
201603 -0.358 100.470 -0.470
201606 -0.388 101.688 -0.503
201609 -0.500 101.861 -0.647
201612 -0.431 101.863 -0.558
201703 -0.351 102.862 -0.450
201706 -0.221 103.349 -0.282
201709 -0.159 104.136 -0.201
201712 -0.185 104.011 -0.234
201803 -0.081 105.290 -0.101
201806 -0.094 106.317 -0.117
201809 -0.096 106.507 -0.119
201812 -0.126 105.998 -0.157
201903 -0.115 107.251 -0.141
201906 -0.115 108.070 -0.140
201909 -0.114 108.329 -0.139
201912 -0.081 108.420 -0.098
202003 -1.528 108.902 -1.849
202006 -0.369 108.767 -0.447
202009 0.199 109.815 0.239
202012 -0.073 109.897 -0.088
202103 0.033 111.754 0.039
202106 1.967 114.631 2.261
202109 -0.115 115.734 -0.131
202112 -0.065 117.630 -0.073
202203 -0.158 121.301 -0.172
202206 -0.170 125.017 -0.179
202209 -0.045 125.227 -0.047
202212 -0.102 125.222 -0.107
202303 -0.148 127.348 -0.153
202306 -0.279 128.729 -0.286
202309 -0.047 129.860 -0.048
202312 -0.107 129.419 -0.109
202403 -0.225 131.776 -0.225

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


XBiotech  (STU:4XB) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


XBiotech Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of XBiotech's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


XBiotech (STU:4XB) Business Description

Industry
Traded in Other Exchanges
Address
5217 Winnebago Lane, Austin, TX, USA, 78744
XBiotech Inc is a United States based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

XBiotech (STU:4XB) Headlines

No Headlines